|Articles|August 9, 2019
Clear Advantages for Characterizing Critical Quality Attributes (CQAs) of Biopharmaceutical Products
Author(s)Agilent
• Streamlined separations for intact proteins, peptide mapping, glycans analysis • LC/Q-TOF enhanced workflows
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Trends in Formulation eBook October 2025
2
In KPMG's CEO Outlook, AI, Regulatory Demands, and Supply Chain Risk Rank High
3
New Cellevate Nanofiber Microcarriers Aim to Transform Vaccine Manufacturing Processes
4
Analytics, Automation, and Quality Driving the Next Era of Drug Development
5
